FLJ44635 Inhibitors denote a specific category of chemical compounds designed to selectively hinder the activity of the FLJ44635 gene product. FLJ44635, also known as C6orf58, is a protein encoded by a gene within the human genome. Proteins like FLJ44635 are typically subjects of scientific curiosity as researchers strive to decipher their involvement in cellular processes, ranging from signal transduction and transcriptional regulation to protein-protein interactions.
To develop FLJ44635 Inhibitors, researchers would delve into the structural characteristics of the gene product, seeking to understand its potential interactions within cellular pathways. These inhibitors are meticulously designed for specificity, aiming to selectively bind to key regions of FLJ44635 and interfere with its normal functions. By employing FLJ44635 Inhibitors in experimental settings, scientists can explore the consequences of gene product inhibition on cellular processes, providing insights into the specific molecular pathways influenced by FLJ44635. The study of inhibitors targeting FLJ44635 contributes to the broader exploration of gene function within the human genome, shedding light on the intricate molecular machinery that underlies fundamental biological processes and offering potential avenues for further research and discovery.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D binds to DNA, inhibiting transcription and preventing the synthesis of FLJ44635 mRNA. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide disrupts protein synthesis, leading to a reduction in FLJ44635 expression by inhibiting translation. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $42.00 $214.00 $832.00 $66.00 | 394 | |
Puromycin induces premature termination of protein synthesis, impacting translation and lowering FLJ44635 levels. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Rifampicin inhibits bacterial RNA polymerase, indirectly suppressing FLJ44635 expression by interfering with transcription. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin hinders protein synthesis by blocking peptidyl transferase activity, leading to reduced FLJ44635 synthesis. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
Cordycepin interferes with mRNA synthesis, impacting transcription and contributing to the downregulation of FLJ44635. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
Mycophenolic acid inhibits inosine monophosphate dehydrogenase, indirectly affecting FLJ44635 expression by disrupting purine synthesis. | ||||||
Blasticidin S Hydrochloride | 3513-03-9 | sc-204655A sc-204655 | 25 mg 100 mg | $367.00 $520.00 | 20 | |
Blasticidin S induces premature termination during translation, inhibiting protein synthesis and reducing FLJ44635 levels. | ||||||
Ellipticine | 519-23-3 | sc-200878 sc-200878A | 10 mg 50 mg | $145.00 $569.00 | 4 | |
Ellipticine intercalates into DNA, disrupting DNA structure and inhibiting transcription, leading to decreased FLJ44635 mRNA. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-Fluorouracil interferes with RNA synthesis, affecting the expression of FLJ44635 by disrupting the production of mRNA. | ||||||